mortality/aging
• show increased mortality beginning at 10 months of age
• at 23.5 months of age the probability for dying is 17.5-fold higher for mutants compared to controls
|
cellular
• at 22 months of age
|
nervous system
microgliosis
(
J:188420
)
• detected at 6, 12 and 21 months of age
|
• show a progressive brain ubiquitin pathology as diffuse and granular cytoplasmic neuronal staining in the cortex, CA hippocampus, subiculum, dentate gyrus, thalamus and other subcortical regions
• a 2-fold increase in autofluorescent lipofuscin pigment accumulation in many brain regions
|
astrocytosis
(
J:188420
)
• in deeper cortical layers, hippocampus, and several subcortical regions
• increases with age
|
• results indicate increased cellular aging
|
liver/biliary system
• prominent aggregates of round-to-polygonal foamy histiocytes are seen at 22 months of age within sinusoids in the absence of acid fast bacilli or other inflammatory features
|
• at 22 months of age, disarrayed masses of hepatic plates are seen along with increased microvacuolation, lipofuscinosis, and hyalinosis
• at 22 months of age, regenerative changes are observed including karyomegaly, cytomegaly, and polyploidy of hepatocytes
|
• polyploidy is seen at 22 months of age
|
• at 22 months of age
|
• results indicate increased cellular aging in hepatocytes
|
behavior/neurological
• decrease in the efficiency in finding the invisible platform during acquisition trials
|
• slightly decreased at 15 months of age
|
hematopoietic system
microgliosis
(
J:188420
)
• detected at 6, 12 and 21 months of age
|
immune system
microgliosis
(
J:188420
)
• detected at 6, 12 and 21 months of age
|